Circulogene and Health Alliance’s ImmunoClear (Plasma CfRNA PD-L1) Could Improve Survival Rates

At its core, ImmunoClear harnesses the power of Plasma CfRNA PD-L1 panels, representing a significant leap forward in the quest for personalized medicine and precision therapies. These panels enable clinicians to focus on the expression levels of PD-L1—a protein known for its role in shielding cancer cells from the body’s immune system.  By examining these

Read More